Mattias Höglund
61 – 70 of 162
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Genome-wide transcription factor binding site/promoter databases for the analysis of gene sets and co-occurrence of transcription factor binding motifs.
(
- Contribution to journal › Article
-
Mark
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
(
- Contribution to journal › Article
- 2009
-
Mark
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
(
- Contribution to journal › Article
-
Mark
Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.
(
- Contribution to journal › Article
- 2008
-
Mark
Tissue microarray based analysis of prognostic markers in invasive bladder cancer: Much effort to no avail?
(
- Contribution to journal › Article
-
Mark
Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays
(
- Contribution to journal › Article
-
Mark
Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios.
(
- Contribution to journal › Article
-
Mark
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
(
- Contribution to journal › Article
-
Mark
Recurrent and multiple bladder tumors show conserved expression profiles.
(
- Contribution to journal › Article
-
Mark
Promoter analysis of epigenetically controlled genes in bladder cancer.
(
- Contribution to journal › Article